CN Patent

CN101868452B — 螺环吡咯烷类与其对抗hcv和hiv感染的应用

Assigned to Novartis AG · Expires 2014-08-06 · 12y expired

What this patent protects

本申请描述了可用于治疗、预防和/或改善人类疾病的有机化合物。

USPTO Abstract

本申请描述了可用于治疗、预防和/或改善人类疾病的有机化合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101868452B
Jurisdiction
CN
Classification
—
Expires
2014-08-06
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.